FDA authorises Subsalve oxygen treatment hood to help coronavirus patients
The US Food and Drug Administration (FDA) has issued Emergency Use Authorisation (EAU) for Subsalve’s oxygen treatment hood, in order to help those suffering from coronavirus.
Subsalve’s oxygen hood is a one-piece, soft, single patient use device used for helmet/hooded non-invasive positive pressure ventilation. The ventilation technique has been used in Italy for decades but is a new treatment for North America.
Until the issued EUA, only off-label use of helmet ventilation had been implemented for treating respiratory distress.
During the pandemic, mortality once intubated has been reported to be as high at 80% in the US. However, with the newly available oxygen treatment hood, physicians can proactively treat early respiratory distress and hypoxemia without incubation.
... to continue reading you must be subscribed
Subscribe Today
To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.
